مقالات بحثية تمّ التفويض بإتاحتها للجميع - Kevin Coombesمزيد من المعلومات
عدد المقالات البحثية غير المتاحة للجميع في أي موقع: 2
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
CD Herling, KR Coombes, A Benner, J Bloehdorn, LL Barron, ZB Abrams, ...
The Lancet Oncology 20 (11), 1576-1586, 2019
التفويضات: US National Institutes of Health
Abstract B37: investigating the potential of miR-203 as a therapeutic candidate and its role in the pathobiology of malignant pleural mesothelioma (MPM)
M Suraokar, K Coombes, A Tsao, I Wistuba, Y Zhang, C Chow, D Kim, ...
Clinical Cancer Research 18 (3_Supplement), B37-B37, 2012
التفويضات: US National Institutes of Health
عدد المقالات البحثية المتاحة للجميع في موقع ما: 137
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
التفويضات: US National Institutes of Health
An epithelial–mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor …
LA Byers, L Diao, J Wang, P Saintigny, L Girard, M Peyton, L Shen, Y Fan, ...
Clinical cancer research 19 (1), 279-290, 2013
التفويضات: US National Institutes of Health
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic …
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
التفويضات: US National Institutes of Health, V Foundation, USA
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
NT Ihle, LA Byers, ES Kim, P Saintigny, JJ Lee, GR Blumenschein, A Tsao, ...
Journal of the National Cancer Institute 104 (3), 228-239, 2012
التفويضات: US National Institutes of Health
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1
LA Byers, J Wang, MB Nilsson, J Fujimoto, P Saintigny, J Yordy, U Giri, ...
Cancer discovery 2 (9), 798-811, 2012
التفويضات: US National Institutes of Health
A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition
MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ...
Clinical Cancer Research 22 (3), 609-620, 2016
التفويضات: US National Institutes of Health, LUNGevity Foundation, USA, V Foundation, USA
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases
S Liu, M Umezu-Goto, M Murph, Y Lu, W Liu, F Zhang, S Yu, LC Stephens, ...
Cancer cell 15 (6), 539-550, 2009
التفويضات: US National Institutes of Health
Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology
KA Baggerly, KR Coombes
The Annals of Applied Statistics, 1309-1334, 2009
التفويضات: US National Institutes of Health
Functional proteomic profiling of AML predicts response and survival
SM Kornblau, R Tibes, YH Qiu, W Chen, HM Kantarjian, M Andreeff, ...
Blood, The Journal of the American Society of Hematology 113 (1), 154-164, 2009
التفويضات: US National Institutes of Health
A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers
BT Hennessy, Y Lu, AM Gonzalez-Angulo, MS Carey, S Myhre, Z Ju, ...
Clinical proteomics 6, 129-151, 2010
التفويضات: US National Institutes of Health
Prognostic impact and targeting of CRM1 in acute myeloid leukemia
K Kojima, SM Kornblau, V Ruvolo, A Dilip, S Duvvuri, RE Davis, M Zhang, ...
Blood, The Journal of the American Society of Hematology 121 (20), 4166-4174, 2013
التفويضات: US National Institutes of Health
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
JM Bogenberger, SM Kornblau, WE Pierceall, R Lena, D Chow, CX Shi, ...
Leukemia 28 (8), 1657-1665, 2014
التفويضات: US National Institutes of Health
Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
V Chintalgattu, D Ai, RR Langley, J Zhang, JA Bankson, TL Shih, ...
The Journal of clinical investigation 120 (2), 472-484, 2010
التفويضات: US National Institutes of Health, Howard Hughes Medical Institute
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers
ML Gillison, K Akagi, W Xiao, B Jiang, RKL Pickard, J Li, BJ Swanson, ...
Genome research 29 (1), 1-17, 2019
التفويضات: US National Institutes of Health
Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia
SM Kornblau, D McCue, N Singh, W Chen, Z Estrov, KR Coombes
Blood, The Journal of the American Society of Hematology 116 (20), 4251-4261, 2010
التفويضات: US National Institutes of Health
HOX expression patterns identify a common signature for favorable AML
M Andreeff, V Ruvolo, S Gadgil, C Zeng, K Coombes, W Chen, ...
Leukemia 22 (11), 2041-2047, 2008
التفويضات: US National Institutes of Health
The BATTLE-2 study: a biomarker-integrated targeted therapy study in previously treated patients with advanced non–small-cell lung cancer
V Papadimitrakopoulou, JJ Lee, II Wistuba, AS Tsao, FV Fossella, ...
Journal of clinical oncology 34 (30), 3638-3647, 2016
التفويضات: US National Institutes of Health
miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue
L Ramdas, U Giri, CL Ashorn, KR Coombes, A El‐Naggar, KK Ang, ...
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2009
التفويضات: US National Institutes of Health
يتم تحديد معلومات التمويل والنشر من خلال برنامج كمبيوتر تلقائيًا.